Skip to main content
. 2020 Mar 10;14:1057–1081. doi: 10.2147/DDDT.S237252

Figure 22.

Figure 22

The possible structure–activity relationship of TTR amyloidogenesis inhibitors, including bisayl structures with a linker, flavonoids and isoflavones, β-minoxypropionic acids, crown ethers and carboranes, and oxazoles.